Secukinumab is an effective and safe treatment for refractory pityriasis rubra pilaris: a case report and literature review.

Secukinumab is an effective and safe treatment for refractory pityriasis rubra pilaris: a case report and literature review. G Ital Dermatol Venereol. 2020 Nov 12;: Authors: Papini M, Russo A, Natalini Y, Troiani L, Cassiani L PMID: 33179881 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33179881?dopt=Abstract

Source: Giornale Italiano di Dermatologia e Venereologia - November 13, 2020 Category: Dermatology Tags: G Ital Dermatol Venereol Source Type: research

More News: Dermatology | Pityriasis | Skin